n/a (BHC.TO)

Toronto: BHC.TO · Precio en tiempo real · USD

9.48

-0.17 (-1.76%)

Al cierre: Aug 19, 2026, 3:59 PM

-1.76% (1D)

Precio de compra	n/a
Capitalización de mercado	3.55B
Ingresos (TTM)	n/a
Beneficio neto (TTM)	n/a
Beta	n/a
EPS (TTM)	-4.08
Ratio PER (TTM)	n/a
Adelante PE	n/a
P/B (TTM)	n/a
P/S (TTM)	n/a
Earnings Date	n/a

Precio de venta	n/a
Volumen	568,992
Volumen medio (20D)	624,120
Abierto	9.63
Anterior Cerrar	9.65
Rango del día	9.26 - 9.76
Rango de 52 semanas	6.10 - 11.08
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de BHC.TO

A detailed description of the company is not yet available....

[Leer más]

Industria n/a

Sector n/a

IPO Fecha n/a

Empleados n/a

Bolsa de Valores n/a

Símbolo bursátil BHC.TO

Perfil completo de la empresa

Sorpresa de resultados

ha publicado sus resultados trimestrales en Jul 29, 2026:

Ingresos de $2.85B falla las estimaciones por $0, con 12.73% Crecimiento interanual.

EPS de 1.26 supera las estimaciones en 0.25, con 38.46% Crecimiento interanual.

Noticias

1 semana hace · Motley Fool

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Much of this was due to a very well-received quarterly earnings report.

2 semanas hace · Insider Monkey

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook

Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set the ground for the company’s profit recovery. In an ...

2 semanas hace · Zacks

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised

BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue and EBITDA guidance after strong earnings.

2 semanas hace · Moby

Bausch Health Companies Inc. Q2 2026 Earnings Call Summary

Moby summary of Bausch Health Companies Inc.'s Q2 2026 earnings call

3 semanas hace · MarketBeat

Bausch Health Cos Q2 Earnings Call Highlights

Bausch Health Cos (NYSE:BHC) reported second-quarter results that management said extended its streak of revenue and adjusted EBITDA growth to 13 consecutive quarters, driven by performance in its Sal...

Página 1 de 2